How to Design Genetic Biosensors for Medical Purposes?

Genetic biosensors lead to a revolutionary integration of genetic engineering and biosensing techniques, suggesting high precision in molecular diagnostics and personalized medicine. These tools use nucleic acids and proteins to enabling early disease diagnosis, and real-time scanning of biological procedures like cancer. Their high sensitivity, specificity, and adaptability make them promising for clinical applications in spite of challenges in optimization and scalability. This review explores the design principles, technological advancements, and biomedical applications of genetic biosensors, focusing on their potential to improve healthcare through personalized medicine and more progress therapeutic interventions.

 <italic id="italic-db0cb01ee10e79d7ea49746a5112f0a4">1- </italic> <italic id="italic-e9a0f9f5957236327bedad1de4cf1b75">Introduction<italic id="italic-3"/></italic>

In the field of molecular diagnosis and medical investigation, the merging of genetic engineering with biosensing techniques has led to the emergence of transformative tools known as genetic biosensors [1]. These complex molecular devices show great ability in disorder detection, drug development, and personalized medicine. Genetic biosensors represent a new category of analytical tools that employ the specificity and sensitivity of genetic factors to detect specific biomarkers or analytes with unique accuracy [2]. Via a detailed assessment of biosensing methods, genetic biosensors have emerged as promising tools for new biomedical applications [3]. The genetic biosensors involve a various array of plans that use genetic components such as nucleic acids, proteins, and genetically modified cells for distinguishing a vast spectrum of targets, from simple to complex molecules [4]. Using the basics of molecular detection and signal transduction, these biosensors show significant potential in simultaneous assessment of biological processes, early problem identification, and evaluation of cure response [5]. As genetic biosensors interface with the molecular procedures, they facilitate accurate medical methods by suggesting quick and precise diagnosis, prognosis, and cure interventions related to personalized medicine [6]. This review article represents a comprehensive overview of the newest advances in genetic biosensors for medical applications, with a focus on modern developments, significant systems of technology, and emerging trends in this field. Through evaluating the profile standards, engineering plan, and uses of genetic biosensors, we aim to annotate their significant impacts on various angles of medical study and healthcare. Additionally, we will point out the challenges and opportunities associated with the complete capacity of genetic biosensors, with a special focus on their integration into clinical function.

Due to their natural capacity for a high level of sensitivity, specificity, and several abilities, genetic biosensors can work as powerful tools for improving our knowledge of complex biological processes, suggesting disorder symptoms, and speeding the progress of precision medication. The following part will provide the divergent applications of genetic biosensors in disease diagnosis, drug evaluation, ecological tracking, and more, focusing on their key role in promoting the future of medical fields and medical supply.

<italic id="italic-29b0f01b9a2f42d3b8950480d78b2141">2- </italic> <italic id="italic-e24777fd42d6956526140da8dda580a1">Genetic Biosensors<italic id="italic-ba61cb871ebaaf13147e9d4b0935bf0d"/></italic>

Genetic biosensors are modern molecular devices that recruit genetic elements to identify target substances with exceptional precision and sensitivity. Combining the specific binding qualities of nucleic acids, proteins, and genetically modified cells, these biosensors present a flexible form for real-time evaluation of biological processes and disorder biomarkers [7]. For instance, RNA-related biosensors relying on aptamers particular to target particles, such as the theophylline-binding RNA aptamer Theoph-1, facilitate selectively recognizing and quantifying small factors in complex biological materials [8]. Additionally, genetic biosensors using reporter genes, like the green fluorescent protein (GFP) gene, enhance visual tracking of cellular responses to induction, providing the origin for dynamic scanning and high-throughput assessment usage in medical study [9].

The involvement of genetic biosensors in medical fields shows great potential for upgrading personalized medicine, disorder diagnostics, and medical care. Genetic biosensors produced with gene editing approaches, such as CRISPR-linked devices intended for targeting particular genetic mutations (e.g., the BRAF V600E mutation related to melanoma), create a powerful method for accurate diagnostics and special treatment [10-12]. Furthermore, the advances of cell-based biosensors using genetically modified cell lines, generating manufactured facilities, facilitate drug expansion and pharmacological evaluation [13, 14]. As the topic of genetic biosensors is growing, their introduction into clinical applications and applied studies is aimed at improving the molecular diagnosis and personalized medicine. Genetic biosensors presented high sensitivity in detecting biomarkers at small concentrations, making them useful tools for medical goals. By genetic replication methods, such biosensors can recognize even the smallest amounts of markers, with a cut-off of detection as low as picomolar or femtomolar amounts [15]. This sensitivity causes early detection and tracking of disease, vital for a precision cure. However, problems may appear regarding background noise and interference, affecting the precision of the results.

Taking into account specificity, genetic biosensors differentiate between targeted biomarkers and non-specific signals accurately, assuring proof and precise diagnosis. By specific DNA or RNA probes, genetic biosensors can selectively bind to the targeted biomarkers, decreasing false positives and increasing tracking accuracy. Despite this specificity, problems emerge in cross-reactivity with closely linked molecules, needing precise design and proof of biosensor agents [16, 17].

Considering speed, genetic biosensors reduce response times, with detection often between minutes to hours, according to the test strategy. This quick response time is helpful for point-of-care applications, causing early diagnosis and on-time therapeutic action [18]. Though genetic biosensors act faster than common settings in most cases, their overall efficacy can be impacted by the need for additional processing stages for special, complex tests. Additionally, there are differentiations in the potential of genetic biosensors; many are designed to be quickly applied in limited-source environments or in the field, whereas the rest may require distinct equipment and information, causing them to be inaccessible in a lot of situations [19].

<italic id="italic-5569a449a67a7de6b84c3f4e16b75cb7">3- </italic> <italic id="italic-f9322e2ed3c4f896f4cfd28a34180719">The role of Genetic biosensors in medicine<italic id="italic-e078aa3dd490dbbdaa5b647e6244dae6"/></italic>

Genetic biosensors are a novelty in medical studies, offering flexible devices for accurate and sensitive recognition of targets in complex biological procedures. These biosensors, using genetic agents such as aptamers, engineered proteins, and reporter genes, upregulate personalized medicine and disorder diagnosis [5]. For instance, aptamers such as the theophylline-binding RNA aptamer Theoph-1 recognize specific small molecules selectively with proper sensitivity [20]. Additionally, genetic biosensors using reporter genes like green fluorescent protein (GFP) visually monitor cellular reactions to external forces, enabling dynamic imaging and high-throughput screening in various medical studies [5].

Genetic biosensors in medical applications revolutionize disorder diagnosis, drug design, and personalized medication. As this field improves, genetic biosensors will play a fundamental role in promoting translational research and generating the next generation of molecular diagnostics and effective medicine [21].

Genetic biosensors offer unique, quick identification abilities, revolutionizing the frequency and reliability of diagnosis and monitoring in medicine. Biosensors diagnose disorders fast through quickly recognizing biomarkers or genetic mutations, causing therapeutic intervention and monitoring of therapeutic consequences. This real-time potential is particularly essential in emergency clinics and infection management, in which rapid function significantly affects sufferer responses [22]. The potential of genetic biosensors to differentiate between nearly linked biomolecules and decrease false positives enhances diagnostic reliability, essential for immediate disease diagnosis and tracking [7]. This personalized system allows for tailored therapeutics according to individual genetic profiles and an individual’s unique genetic makeup, ultimately optimizing therapeutic responses and reducing side effects [23].

Genetic biosensors have various functions in biomedical studies, confirming their role and impact across different domains. In disorder diagnosis, genetic biosensors have been active in finding specific genetic mutations linked with diseases like cancer, cystic fibrosis, and genetic disorders such as sickle cell anemia. By targeting these genetic biomarkers, biosensors offer early and accurate diagnosis, helping in personalized cure methods [23, 24]. Nevertheless, challenges may arise in recognizing mutations with low rates or high genetic variation, influencing their sensitivity and specificity.

In drug screening, genetic biosensors play a main role in evaluating drug effectiveness and toxicity by monitoring cellular responses to medication compounds. Such biosensors can identify changes in gene expression, protein function, or metabolic pathways, providing valuable insights into medicine’s mechanisms and side effects [7, 25]. Moreover, genetic biosensors track cellular metabolism, assessing fundamental metabolites such as glucose, lactate, and ATP amounts. By monitoring metabolic modifications in real-time, biosensors enable a deeper comprehension of cellular procedures and metabolic disorders [26-28]. In environmental tracking, genetic biosensors are used for identifying pollutants, pathogens, and toxins in water resources, air quality, and soil. These biosensors supply quick and sensitive recognition, presenting rapid environmental danger identification and mitigation approaches. However, challenges emerge in ensuring biosensor stability and specificity in complex environmental cases [29].

Genetic biosensors have revolutionized therapeutic investigation and healthcare with their enhanced sensor sensitivity, novel model systems, and advanced imaging methods. Multiple important applications of genetic biosensors in medical studies are involved (Figure 1):

1. Early diagnosis and point mutation recognition: Using biosensors to recognize specific genetic biomarkers for diseases like cancer, Alzheimer’s, and infectious diseases. For instance, NOX-A12, an RNA aptamer, attaches to CXCL12 as a chemokine in cancer progression and metastasis. Clinical assessment of NOX-A12 presents its ability to disrupt the CXCL12-CXCR4 interaction, enhancing immune responses against hematologic malignancies and solid tumors [30].

2. Medical tracking: Evaluating drug effectiveness and toxicity by monitoring cellular interactions using genetic biosensors. As a result of the Warburg effect, several tumors show significantly lower NAD+/NADH ratios than normal cells. The SoNar sensor was produced via insertion of a cpYFP construct between subunits of NAD (H) binding protein Rex arising from Thermus aquaticus (T-Rex). NAD+ saturation of SoNar increased fluorescence excited at 485 nm, whereas NADH binding progresses fluorescence excited at 420 nm. SoNar may particularly bind to NAD+ or NADH (Kd ≈ 5.0 μM and ≈ 0.2 μM, respectively, at pH 7.4). It is a pH-stable, systematic ratiometric detector for NAD+, NADH, and their proportion. SoNar presents an 8-fold dynamic difference in living cells. Zhao et al. introduced SoNar as a proper candidate for HTS of the NAD+/NADH ratio in live tumors with drug tracking potentials [31].

3. Intracellular conception: Visualizing gene expression and cellular procedures in real-time with biosensors designed for imaging. Lately, several genetically expressed fluorescent probes have been developed to present NO and its products in single cells. But only a couple of researchers used such helpful probes. It may require a while, as most of the researchers apply NO selective GES, which can permit studying on presently finished subjects. Novel FP-linked probes with enhanced sensitivity, selectivity, spectral effects, and relevance will motivate researchers in different areas to guide instructive single-cell NO imaging assessments in a short time. Such other GES, including unique Ca2+ markers and NO probes, may be applied in studies on NO signals in animal investigations. Along with the preferences of geNOps, NOA-1, MT-FRET, pnGFP, and sNOOOpy, the scientific frame has been established nowadays, we must follow a way in a structured and concentrated behavior [32].

4. Environmental tracking: identifying pollutants, toxins, and microbial contaminants in air, water, and soil by biosensors. The devices of resistance and detoxification for toxic metals were identified in the compounds of special complete-cell biosensors. The regulatory settings included regulatory proteins that might bind metals and promoter areas that cause detoxification or signal transduction interactions. For example, arsR and the promoter sequence from Geobacter sulfurreducens could be combined with a fluorescence reporter to enable arsenic tracking with a ppb recognition limitation. Fundamentally, the toxicants entered into the cells and subsequently activated detoxification and metabolism operons. Nevertheless, it has been approved that the two-component adjustment might be integrated into bacterial biosensors for sensing extracellular pollution. The regulatory membrane protein can attach chemicals and phosphorylate the other regulatory proteins that induce the signal transduction [33].

5. Signal Transduction Assessments: Studying signal transduction pathways and protein interactions by biosensors for detailed signal transduction network analysis. Based on the Findeiß et al. study, the plasma membrane can involve extremely highly divided areas for kinases. For example, receptor-associated kinases such as JAK could be organized by inducing STAT as a fundamental spatiotemporal factor that cannot yet be examined visibly. Findeiß et al. overcome this obstacle by presenting a sensitive genetically expressed biosensor based on fluorescence resonance energy transfer (FRET). They monitored the local promotion of STATs and enhanced their amount and kinetic alterations in different situations in biological systems. The visualization of the STAT dynamics aids in interpreting and associating practical signal transduction with single-cell RNA sequencing methods to show alteration within stem, progenitor, and immune cells [34].

Through such applications, genetic biosensors have significantly progressed our knowledge of biological tools, enabled immediate disorder diagnosis, and led to the development of targeted treatments, finally contributing to improved healthcare outcomes and accurate medicine methods.

 <italic id="italic-c04246866c4fce74c2577b180898b7a9">4- </italic> <italic id="italic-aa4ee1160e7a47517f398f7bb2b7f01c">Design and Development<italic id="italic-1cc7ebffb1f0be45c531e746167e3c00"/></italic>

In the design of genetic biosensors for biomedical uses, careful selection of genetic elements like transcription factors and riboswitches is essential. Transcription factors are important regulators of gene expression, suggesting precise control over sensor output in reaction to specific biological signals [19, 35]. Their selection is according to their ability to bind to target DNA sequences and adjust gene transcription efficiently. On the other hand, riboswitches are RNA molecules that can change their structure upon attaching specific ligands, enabling direct detection and response to cellular metabolites or small molecules. When choosing riboswitches for biosensors, considerations involve their ligand-binding specificity, structural stability, and responsiveness to targets [36, 37].

Riboswitches may also be engineered by the CRISPR approach to diagnose metabolites or ions critical for developmental checkpoints. For example, small molecule-inducible riboswitches have been manipulated to enable reversible, dose-dependent management of gene expression in vitro and in vivo, showing their potential use for biological investigation [38]. In a study, Bruckhoff et al. engineered splice-controlling riboswitches to manage exon skipping, enabling chemically inducible isoform switching in vitro and suggesting a new method for gene regulation via alternative splicing [39]. Potential and Optimization of Mammalian Splice Riboswitches for the Regulation of Exon Skipping-Dependent Gene Expression and Isoform Switching within the ALOX5 Gene [39]. These genetic parts are fundamental for constructing biosensors that can accurately recognize and report biological signals, making them valuable means in advancing biomedical study and diagnostics.

<italic id="italic-4">4-1- </italic> <italic id="italic-5">Fundamentals of Engineering:<italic id="italic-6"/></italic>

The design of genetic revolutions encompasses the organization of genetic components such as promoters, transcription factors, and reporter genes in a way that facilitates precise control over gene expression levels in response to specific biological signals. These revolutions usually employ feedback processes and signal amplification methods to increase sensor sensitivity and dynamic spectrum [40]. Sensor structure in genetic biosensors is accurately engineered to identify and assess specific biomolecules within biological systems. Essential components involve sensor factors such as riboswitches or aptamers that interact with target molecules, causing conformational modifications that are transduced into measurable results. Coupling these sensor factors with signal transduction pathways and output modules such as fluorescent proteins or enzymes allows for the conversion of molecular recognition events into quantifiable signal transduction, enabling the precise identification and screening of biomolecule levels in real-time [41, 42].

Generally, the construction fundamental of genetic biosensors for biomedical applications intricately weaves together genetic uses and sensor structures to create robust and sensitive identification platforms. By leveraging the interactions between genetic components and sensor factors, these biosensors enable the precise assessment of specific biomolecules in complicated biological environments, paving the way for improvement in disorder detection, therapeutic screening, and basic evaluation. The modular nature of genetic biosensors allows customization and optimization to target different biomolecules of interest, making them versatile means for addressing a wide range of biomedical challenges and driving novelty in precision medicine [43, 44].

<italic id="italic-74ed26a9867df60043278ddcec302fcf">4-2- </italic> <italic id="italic-dd60ac9a3db86bdf06d70e4a4f1f8fa9">Performance Metrics and Evaluation Criteria<italic id="italic-1c87ee6846e88d0157f3e0930b1c5224"/></italic>

When assessing and optimizing genetic biosensors for biomedical applications, both in vitro and in vivo examination are key components. In vitro testing includes assessing the efficacy and specificity of genetic biosensors in controlled laboratory settings. Assessment of metrics like sensitivity, dynamic range, response time, and signal-to-noise ratio is usually used to measure biosensor performance [45, 46]. Experimental designs frequently involve calibration curves, dose-response research, and specificity assays to validate the biosensors’ ability to accurately recognize and measure target biomolecules in complicated biological samples. In contrast, in vivo evaluation emphasizes visualizing and tracking the manner of genetic biosensors within living cells. Different imaging methods like optical imaging, magnetic resonance imaging (MRI), and computed tomography (CT) can be employed to monitor the spatial distribution and temporal dynamics of biosensor function in real-time. Optimizing biosensors for in vivo applications includes considerations of biocompatibility, tissue penetration, signal stability, and longevity to ensure reliable discharge and minimal interference with physiological procedures [47, 48].

Successful optimization of genetic biosensors for biomedical applications needs a comprehensive understanding of their performance characteristics and manner in both controlled laboratory environments and living systems. Using a combination of in vitro and in vivo testing strategies allows investigators to completely evaluate biosensor functionality, specificity, and reliability across various experimental contexts. By carefully considering key parameters like sensitivity, specificity, spatial resolution, and signal persistence, scientists can fine-tune genetic biosensors to meet the specific requirements of biomedical applications, facilitating their successful translation into practical means for disorder diagnosis, therapeutic screening, and biological investigation [46].

<italic id="italic-06f142644dfb967ca06a141e3c141d6f">4-3- </italic> <italic id="italic-09db111a7090ff1e643b078eeeb29d44">The significance of genetic biosensors<italic id="italic-2bcf8af541a69f179b2067e28e44704b"/></italic>

Genetic biosensors are valuable means in biomedical study, especially in the field of natural product biosynthesis. These biosensors are designed to detect specific biological molecules or processes within living cells, allowing researchers to monitor and regulate the production of bioactive compounds such as antibiotics, anticancer agents, and immunosuppressants. For example, scientists have successfully used genetic biosensors to track the synthesis of artemisinin, a potent antimalarial compound that originates from the sweet wormwood plant. By integrating biosensor systems into microbial hosts, scientists can optimize metabolic pathways and increase the outcome of natural products, finally contributing to the development of more efficient drugs for different disorders [49, 50].

In the realm of biomedicine, genetic biosensors play a key role in disorder management and diagnosis. These biosensors can be engineered to diagnose specific biomarkers linked with certain problems, enabling immediate detection and accurate tracking of disorder progression. For example, genetic biosensors detect tumor markers in blood samples, providing a non-invasive strategy for diagnosing different kinds of cancer at an early stage [51, 52]. Furthermore, genetic biosensors can be instrumental in the development of new therapeutic strategies, like personalized medicine methods that target specific molecular pathways in patients. By harnessing the power of genetic biosensors, researchers and clinicians can revolutionize the way diseases are diagnosed, treated, and controlled in the medical field [53, 54].

In the realm of genetic biosensors for biomedical applications, the future holds promise in increasing sensor sensitivity, pioneering imaging techniques, and advancing model systems. In striving for improved sensor sensitivity, scientists are finding innovative nanomaterials, signal amplification approaches, and bioconjugation strategies to enhance detection signals and lower detection limits, enabling the accurate monitoring of molecular targets within biological samples [55]. Concurrently, novel imaging techniques like super-resolution microscopy and spectroscopic imaging are revolutionizing the visualization of molecular interactions and cellular processes, providing researchers with unprecedented insights into biological mechanisms at the subcellular level [56, 57].

Furthermore, the development of advanced model systems, leveraging organ-on-a-chip technology, organoids, and patient-derived cells, is redefining the landscape of genetic biosensor applications in biomedical research. These cutting-edge model systems faithfully recapitulate complex physiological environments, disease conditions, and drug responses, offering a platform for validating biosensor performance in clinically relevant settings and facilitating the discovery of novel biomarkers and therapeutic targets [58, 59]. By integrating enhanced sensor sensitivity, state-of-the-art imaging modalities, and innovative model systems, the future of genetic biosensors in biomedicine promises to revolutionize diagnostics, drug development, and personalized treatment strategies, ushering in a new era of precision medicine and transformative healthcare innovations.

<italic id="italic-6e9fd8a97efd428b916200f40a6c2f97">5- </italic> <italic id="italic-05a52c9562e60062820b1b7200fced97">Introduction of Genetic Biomarkers<italic id="italic-a84d09c47626c02a34c87410423d9e60"/></italic>

The selection and integration of genetic markers with biomedical devices for genetic biosensors in biomedical applications involves a meticulous process guided by key considerations to ensure optimal performance and relevance in high-impact applications. Initially, the choice of genetic markers is critical and hinges upon factors such as the specificity, sensitivity, and clinical significance of the biomarkers in detecting and monitoring specific biological processes or disease states [60, 61]. Genetic markers selected should exhibit high selectivity towards the target analytes while maintaining robustness in complex biological matrices. Subsequently, the integration of these genetic markers with biomedical devices necessitates the design and fabrication of sensors that can efficiently capture, transduce, and amplify signals generated by the interaction between the markers and target molecules [62]. Critical considerations in this integration process include the development of biocompatible and stable sensor platforms, the incorporation of signal amplification strategies, and the optimization of detection mechanisms to enhance sensitivity and accuracy.

Overall, the successful selection and integration of genetic markers with biomedical devices for genetic biosensors hold profound implications for high- impact biomedical applications, offering significant advancements in diagnostics, personalized medicine, and therapeutic monitoring. By effectively leveraging the unique molecular signatures provided by genetic markers, these biosensors can enable rapid and precise detection of biomolecules, facilitate early disease diagnosis, monitor treatment responses, and customize therapies based on individual genetic profiles. The seamless integration of advanced sensor technologies and genetic markers in biosensors not only enhances analytical capabilities but also paves the way for innovative biomedical devices that have the potential to revolutionize healthcare delivery and improve patient outcomes on a broad scale.

<italic id="italic-794a8ce064620242935673c3f480e718">5-1- </italic> <italic id="italic-f69e2885db01861679ea0280feeeaf8c">Introduction of Genetic Marker<italic id="italic-84869530c531ba5e09ad5ba78af745bc"/></italic>

Molecular genetic markers, encompassing single- nucleotide polymorphisms (SNPs), gene mutations, and epigenetic alterations, play a pivotal role in distinguishing disease biomarkers or specific biological processes with high specificity and accuracy [63, 64]. Complementarily, gene expression profiles offer valuable insights into the dynamic regulation of gene activity [65, 66] and molecular pathways, providing a comprehensive view of cellular responses and disease states [67, 68]. By integrating both molecular genetic markers and gene expression data, genetic biosensors can achieve enhanced detection capabilities and diagnostic accuracy, facilitating breakthroughs in high-impact scientific research across diverse biomedical fields such as disease diagnostics, therapeutics development, and personalized medicine [2, 16]. This integrative approach not only enables the precise profiling of genetic signatures but also propels advancements in translational research, offering transformative opportunities for targeted treatments and biomarker-driven clinical interventions in precision healthcare settings.

<italic id="italic-63ace5f3c90bbcb36f3495d74dbefc1a">5-2- </italic> <italic id="italic-bab0ec345a2bb8984995a6b4066898ec">Embedding into medical tools<italic id="italic-cfd0f8ee9548d44eb200c8525e289ad1"/></italic>

The integration of genetic biosensors with biomedical devices represents a significant advancement in the field of biomedicine, offering a promising avenue for precision diagnostics and personalized healthcare [69, 70]. By harnessing the power of genetic information in real-time monitoring, these integrated systems hold the potential to revolutionize disease detection, treatment monitoring, and therapeutic interventions [71]. Recent developments have showcased the ability of genetic biosensors to detect specific biomarkers with high sensitivity and specificity, paving the way for early disease detection and tailored treatment strategies [72]. The convergence of genetic biosensors with biomedical devices opens up new possibilities for continuous health monitoring, point-of-care diagnostics, and targeted drug delivery systems. Future directions in this field involve optimizing sensor performance, enhancing device miniaturization, and exploring novel applications in areas such as wearable technology and implantable devices, ultimately shaping the landscape of human healthcare with precision and efficiency [69].

The process of genetic marker selection for genetic biosensors in biomedical applications is a crucial step in ensuring the accuracy and reliability of these diagnostic tools. The selection of molecular genetic markers and gene expression profiles plays a pivotal role in determining the sensitivity and specificity of the biosensors in detecting specific biomolecules associated with various diseases. This process involves identifying genes or genetic sequences that are known to be biomarkers for specific conditions, such as genetic mutations, gene expression levels, or specific genetic variations. By carefully selecting the appropriate genetic markers, researchers can optimize the performance of genetic biosensors, enhancing their ability to accurately detect and quantify target molecules in biological samples. This meticulous selection process is essential for the successful development of genetic biosensors that meet the stringent requirements of biomedical applications, ensuring their effectiveness in clinical diagnostics and personalized medicine.

<italic id="italic-4b90ce09ec5811e0b041a37ff649bd37">5-3- </italic> <italic id="italic-13b613e95db361cfc7c12a67b0703092">The importance in treatment<italic id="italic-089fc181323ca5cbc215a08e330390de"/></italic>

Genetic biosensors have appeared as powerful tools in the field of personalized medicine, suggesting tailored diagnostic and cure strategies according to individual genetic variations. By such biosensors, clinicians can detect specific genetic biomarkers linked with an individual’s susceptibility to certain diseases or their response to specific treatments, enabling a precision medical approach that considers the unique genetic makeup of each sufferer [1]. The flexibility of genetic biosensors enables not only the recognition of genetic mutations and variations but also the tracking of gene expression patterns in real-time, providing valuable views into the molecular mechanisms underlying disorder progression and cure response. This personalized strategy has the potential to revolutionize healthcare by optimizing cure regimens, minimizing side effects, and improving patient outcomes [73]. By targeting specific genetic biomarkers or molecules related to different pathological conditions, these biosensors can identify minute modifications in gene expression profiles or detect disease-linked mutations with high precision [73].

The real-time monitoring of the potentials of genetic biosensors not only enables quick and accurate disorder diagnosis but also leads to continuous tracking of disease progression and cure response, providing clinicians with valuable data for optimizing medical interventions. This personalized and precise strategy for disease diagnosis decreases healthcare costs and advances our knowledge of complicated diseases at the molecular level [74].

Advancements in sensor sensitivity are fundamental for overcoming the limits of detection and precision in genetic biosensors. Approaches to achieve this involve the exploration of new materials with increased optical properties, surface changes to optimize sensor-target interactions, and the integration of nanotechnology applications for signal amplification and increased signal-to-noise ratios [22, 75]. By using these innovative methods, researchers aim to increase the detection restrictions of genetic biosensors, leading to the accurate and real-time tracking of molecular events within biological settings with unprecedented sensitivity. These advancements hold hope for revolutionizing disorder diagnostics, drug development, and personalized medicine by providing clinicians with highly sensitive devices for early detection and precise tracking of biomolecular interactions [76].

In parallel, the study of new model systems represents a border in the evolution of genetic biosensors. Emerging plans like synthetic biology systems, cell-free expression systems, and decreased organ-on-a-chip techniques offer a unique chance to expand the relevance and flexibility of genetic biosensors. These model systems create mimetic environments that nearly mimic physiological conditions, allowing for the testing and validation of biosensor function in complex biological fields [22]. By using these innovative model settings, researchers can gain deeper insights into cellular processes, disorder mechanisms, and drug responses, developing next-generation genetic biosensors for specific biomedical applications. The integration of these new model systems with progressed genetic biosensors accelerates the translation of biosensor techniques from the laboratory to clinical practice, finally advancing precision medicine and personalized healthcare.

<italic id="italic-abe175464f305157b3b8d232570b4e99">6- </italic> <italic id="italic-4f809ec84d6bbe2d8ace3d96e95703fa">Economic effectiveness of genetic biosensors<italic id="italic-5611a3a6ff0c39c7de68d3961cf63055"/></italic>

The use of genetic biosensors in technical applications suggests a cost-effective strategy for healthcare delivery, leading to decreased general healthcare costs and elevated efficiency. For instance, the performance of genotyping biosensors for pharmacogenetics testing allows for the identification of genetic differences that may influence an individual’s response to treatment, thereby decreasing adverse drug reactions and unnecessary cures [77]. In addition, the use of genetic biosensors for early detection of genetic biomarkers related to diseases, like cancer susceptibility, enables proactive and preventive assessments that can reduce the need for expensive treatments at later stages of the disorder. Moreover, the development of point-of-care genetic biosensors, like portable tools for rapid infectious disease evaluation, streamlines the diagnostic procedures, reduces the time to treatment initiation, and decreases healthcare-related costs [78]. Generally, the cost-effectiveness of genetic biosensors in medical applications lies in their potential to optimize cure approaches, control disease progression, and increase healthcare efficiency, ultimately leading to substantial economic benefits for healthcare settings and improved sufferer care. A comprehensive overview of the types, applications, and challenges of genetic biosensors is presented in Table 1.

Aspect Description Examples of Applications Advantages Challenges
Type of Biosensor different types of genetic biosensors (e.g., DNA sensors, RNA sensors, protein biosensors) Pathogen detection, gene expression evaluation High specificity and sensitivity Producing complexity
Detection Method Strategies used for detection (e.g., fluorescence, electrochemical, colorimetric) Real-time PCR, LAMP Rapid consequences and real-time tracking Needs specialized tool
Target Molecule Molecules aimed by the biosensors(e.g., DNA, RNA, proteins, metabolites) Genetic mutations, pathogen recognition Ability to assess specificgenetic sequences Variability in aim molecule stability
Sample Types Biological samples proper for assessment(e.g., blood, saliva, urine, tissue biopsies) Blood tests for genetic diseases Non-invasive sample collection options Sample preparation
Applications in Diagnostics Use of biosensors for disease diagnosis and tracking Cancer diagnostics, infectious diseases Early detection causing better prognosis Accuracy in differentpopulations
Therapeutic Monitoring Monitoring cure effectivenessand patient response Monitoring drug amounts and responses Personalized medicine strategies Divergence in suffererresponses
Point-of-Care Testing Implementation in clinical settings for immediate results Quick testing for STIs or genetic predispositions Enhanced accessibility to healthcare Regulatory and validation obstacles
Research Applications Utilization in academic and pharmaceutical research Gene editing studies, environmental monitoring Enhanced data accuracy and reproducibility Integration with existingresearch workflows
Multiplexing Capability Ability to detect multiple targets simultaneously Simultaneous detection of several pathogens Time-saving andcost-effective Complexity in design and interpretation
Data Analysis Techniques Methods used for processing and interpreting data Machine learning, statistical analysis Improved accuracy in results High volume of data management
  Challenges in gaining approval for clinical use Compliance with FDA or CE markings Potential for innovation in diagnostics Long timelines for approval processes
Cost-effectiveness Economic feasibility of biosensor production and application Cost comparisons with traditional methods Reduction in healthcare coststhrough efficient testing High manufacturing and development costs
User-friendliness Ease of use for clinicians and researchers User interfaces, automated systems Greater adoption in clinical practice Need for training and support
Field Deployment Application in real-world settings, including remote areas Portable diagnostic devices Accessibility in l ow-resource settings Stability and robustness in diverse environments
Integration with IT Systems Compatibility with electronic health records and laboratory information systems Data sharing between labs and clinics Streamlined workflows andimproved patient management Cybersecurity concerns
Ethical Considerations Ethical implications of genetic testing and data privacy Informed consent processes Increased awareness and education Potential for misuse of genetic information

The potential of genetic biosensors to collect and evaluate genetic information faces multiple serious ethical questions, specifically around privacy, agreement, equity, and safety. To begin, genetic data is extremely personal and can be predictive not only for the person but also for their family members. Biosensors, particularly those used in point-of-care systems or presented directly to consumers, can produce sensitive information. Subsequently, receiving informed consent for genetic testing through these biosensors can be completely challenging. Ultimately, collecting genetic data, especially concerning disease risk, can have significant psychological effects [22, 79].

<italic id="italic-ec5fb5eb513f04295b643b974e5693b1">7- </italic> <italic id="italic-60c36d3f68434fe4ce0bb805a48517d0">Conclusion and Future perspectives<italic id="italic-359f88c8f473ea9140c8ce28a5086036"/></italic>

The future of genetic biosensors holds promising progress in technology, especially in the integration of Artificial Intelligence (AI) to increase their potential. AI-driven genetic biosensors can revolutionize medical studies and applications by permitting more precise and effective detection and assessment of genetic data. One application lies in the production of AI-increased genetic biosensors for early diagnosis and tracking of genetic biomarkers linked with complex disorders, like cancer. AI algorithms can assess vast amounts of genetic information to detect patterns and trends that may be typical of disease progression, enabling proactive and personalized cure methods. Another exciting anticipation is the use of AI in genetic biosensors for real-time tracking of infectious disease outbreaks. By integrating AI algorithms with portable genetic biosensors, quick identification and monitoring of pathogen mutations can be reached, facilitating proper public health interventions. In addition, AI-increased genetic biosensors can be used in precision medicine strategies, where AI algorithms can assess genetic divergence and anticipate individual responses to cures, causing more personalized and effective healthcare interventions. AI algorithms can evaluate vast amounts of genetic information to detect patterns and trends that may be typical of disease progression, enabling proactive and personalized cure methods. Another exciting anticipation is the use of AI in genetic biosensors for real-time tracking of infectious disease outbreaks. AI algorithms, especially those based on deep learning, have the remarkable potential to sift through vast multi-omics datasets think genomics, transcriptomics, and proteomics to reveal complex predictive patterns that traditional statistical strategies usually miss. It can also use reinforcement learning algorithms to plan the perfect CRISPR guide RNA, ensuring it hits the aim effectively while decreasing off-target impacts. This strategy significantly increases the accuracy of a CRISPR-based biosensor even before we begin producing it in the lab. Moreover, a well-trained machine learning model can evaluate this signal in real-time, not just assessing the aim’s concentration but also eliminating any unclear signals from contaminants. This produces consequences that are not only more reliable but also reproducible.

The integration of AI techniques with genetic biosensors presents a promising direction in progressing medical study and applications, with the potential to significantly impact healthcare results and patient care.

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors agree to publish this paper.

Availability of data and material

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Author contribution statement

All authors listed have significantly contributed to the design, the development and the writing of the manuscript. All authors have read and agreed to the published version of the manuscript.

<bold id="bold-1">References<bold id="bold-2"/></bold> 01 08 100301 9 2024 10.1016/j.talo.2024.100301 Gaba S Chauhan N Chandra R Jain U Talanta Open Future advances of artificial biosensor technology in biomedical applications 01 3 05 188726 1877 2022 10.1016/j.bbcan.2022.188726 Lino C. Barrias S. Chaves R. Adega F. Martins-Lopes P. Fernandes J. R. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer Biosensors as diagnostic tools in clinical applications 108293 167 2021 10.1016/j.measurement.2020.108293 Mohankumar P Ajayan J Mohanraj T Yasodharan R Measurement Recent developments in biosensors for healthcare and biomedical applications: A review 01 2 04 100113 29 2024 10.1016/j.slast.2023.10.005 Chaisupa P Wright RC SLAS Technology State-of-the-art in engineering small molecule biosensors and their applications in metabolic engineering 11 11 1528 9 2021 10.3390/biomedicines9111528 Ovechkina VS Zakian SM Medvedev SP Valetdinova KR Biomedicines Genetically Encoded Fluorescent Biosensors for Biomedical Applications 01 01 212-224 4 2023 10.1016/j.smaim.2022.10.003 Wang C Zeng H Liu K Lin Y Yang H Xie X Wei D Ye J Smart Materials in Medicine Biosensor-based therapy powered by synthetic biology 115860 126 2020 10.1016/j.trac.2020.115860 Lu X Cui M Yi Q kamrani A TrAC Trends in Analytical Chemistry Detection of mutant genes with different types of biosensor methods 5 05 659-667 6 2000 10.1017/s1355838200000169 Zimmermann G. R. Wick C. L. Shields T. P. Jenison R. D. Pardi A. RNA (New York, N.Y.) Molecular interactions and metal binding in the theophylline-binding core of an RNA aptamer 26 24 12 11707-11794 118 2018 10.1021/acs.chemrev.8b00333 Greenwald EC Mehta S Zhang J Chemical Reviews Genetically Encoded Fluorescent Biosensors Illuminate the Spatiotemporal Regulation of Signaling Networks 2 02 202 13 2023 10.3390/bios13020202 Kumaran A Jude Serpes N Gupta T James A Sharma A Kumar D Nagraik R Kumar V Pandey S Biosensors Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application 16 09 10 2022 10.3389/fbioe.2022.986233 Chen K Shen Z Wang G Gu W Zhao S Lin Z Liu W et al Frontiers in Bioengineering and Biotechnology Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis 15 09 450-458 8 2017 10.1016/j.omtn.2017.05.009 Yang M Wei H Wang Y Deng J Tang Y Zhou L Guo G Tong A Molecular Therapy. Nucleic Acids Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1 9 01 7989 24 2023 10.3390/ijms24097989 Chen S Chen X Su H Guo M Liu H International Journal of Molecular Sciences Advances in Synthetic-Biology-Based Whole-Cell Biosensors: Principles, Genetic Modules, and Applications in Food Safety 29 09 10 2022 10.3389/fcell.2022.1007893 Kim H Baek I Seong J Frontiers in Cell and Developmental Biology Genetically encoded fluorescent biosensors for GPCR research 21 01 7327 27 2022 10.3390/molecules27217327 Li M Jiang F Xue L Peng C Shi Z Zhang Z Li J et al Molecules Recent Progress in Biosensors for Detection of Tumor Biomarkers 01 02 113739 197 2022 10.1016/j.bios.2021.113739 Wang Q Wang J Huang Y Du y Zhang Y Cui Y Kong D Biosensors & Bioelectronics Development of the DNA-based biosensors for high performance in detection of molecular biomarkers: More rapid, sensitive, and universal 28 2021 10.17533/udea.vitae.v28n3a347259 Barbosa L Insuasty Cepeda D León-Torres A Arias Cortes MM Rivera Monroy Z Castaneda J Vitae Nucleic acid-based biosensors: Analytical devices for prevention, diagnosis and treatment of diseases 08 03 149-156 1101 2020 10.1016/j.aca.2019.12.023 Chinnappan R Eissa S Alotaibi A Siddiqua A Alsager OA Zourob M Analytica Chimica Acta In vitro selection of DNA aptamers and their integration in a competitive voltammetric biosensor for azlocillin determination in waste water 7 07 797-810 38 2020 10.1016/j.tibtech.2020.03.013 Hossain GS Saini M Miyake R Ling H Chang MW Trends in Biotechnology Genetic Biosensor Design for Natural Product Biosynthesis in Microorganisms 12 3 02 1017-1029 64 2024 10.1021/acs.jcim.3c01454 Akhter S Tang Z Wang J Haboro M Holmstrom ED Wang J Miao Y Journal of chemical information and modeling Mechanism of Ligand Binding to Theophylline RNA Aptamer 303 305 2 2017 10.1080/23808993.2017.1395691 Dincer C Bruch R Schumann S Urban G Expert Review of Precision Medicine and Drug Development Biosensors and personalized drug therapy: What does the future hold? 100257 5 2023 10.1016/j.sintl.2023.100257 Bhatia D Paul S Acharjee T Ramchiary S Sensors International. . https://doi.org/ Biosensors and their widespread impact on human health 15 12 9 2021 10.3389/fbioe.2021.797831 Jiang H Xi H Juhas M Zhang Y Frontiers in Bioengineering and Biotechnology Biosensors for Point Mutation Detection 03 1 01 1 13 2024 10.3390/biotech13010001 Henderson ML Zieba JK Li X Campbell DB Williams MR Vogt DL Bupp CP et al Biotech (Basel (Switzerland)) Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care 25 1 12 148 22 2020 10.3390/ijms22010148 Potekhina ES Bass DY Kelmanson IV Fetisova ES Ivanenko AV Belousov VV Bilan DS International Journal of Molecular Sciences Drug Screening with Genetically Encoded Fluorescent Sensors: Today and Tomorrow 08 111-121 63 2020 10.1016/j.conb.2020.02.011 Koveal D Díaz-García CM Yellen G Current Opinion in Neurobiology Fluorescent Biosensors for Neuronal Metabolism and the Challenges of Quantitation 1 01 46 14 2024 10.3390/bios14010046 Koo K Kim C Kim T Biosensors Recent Advances in Electrochemical Detection of Cell Energy Metabolism 14 12 06 1920 11 2022 10.3390/cells11121920 White D Yang Q Cells Genetically Encoded ATP Biosensors for Direct Monitoring of Cellular ATP Dynamics 15 4 02 1513 22 2022 10.3390/s22041513 Gavrilaș S Ursachi CS Perța-Crișan S Munteanu F Sensors (Basel, Switzerland) Recent Trends in Biosensors for Environmental Quality Monitoring 2020 Jain S et al Elsevier Nanotechnology applications for cancer chemotherapy 05 5 05 777-789 21 2015 10.1016/j.cmet.2015.04.009 Zhao Y Hu Q Cheng F Su N Wang A Zou Y Hu H et al Cell Metabolism SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents 20 11 50-58 128 2018 10.1016/j.freeradbiomed.2018.01.027 Eroglu E Charoensin S Bischof H Ramadani J Gottschalk b Depaoli mr Waldeck-Weiermair M Graier WF Malli R Free Radical Biology & Medicine Genetic biosensors for imaging nitric oxide in single cells 1 12 58-80 14 2023 10.1080/21655979.2022.2095089 Huang C Lin C Nguyen MK Hussain A Bui X Ngo HH Bioengineered A review of biosensor for environmental monitoring: principle, application, and corresponding achievement of sustainable development goals 07 3 02 248a 118 2020 10.1016/j.bpj.2019.11.1453 Attar AM Biophysical Journal Genetic Biosensors for Real Time Monitoring of the Activation of Signal Transducers and Activators of Transcription (STAT) 01 01 9863496 2022 2022 10.34133/2022/9863496 Liu Y Yuan G Hassan MM Abraham PE Mitchell JC Jacobson D Tuskan GA et al BioDesign Research Biological and Molecular Components for Genetically Engineering Biosensors in Plants 05 2 11 244-259 592 2016 10.1016/j.gene.2016.07.035 Mehdizadeh Aghdam E Hejazi MS Barzegar A Gene Riboswitches: From living biosensors to novel targets of antibiotics 30 9 08 1990 17 2017 10.3390/s17091990 Findeiß S Etzel M Will S Mörl M Stadler PF Sensors (Basel, Switzerland) Design of Artificial Riboswitches as Biosensors 12 23 12 23331-23346 17 2023 10.1021/acsnano.3c01994 Rovira E Moreno B Razquin N Blázquez L Hernández-Alcoceba R Fortes P Pastor F ACS nano Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals 21 3 03 804-818 14 2025 10.1021/acssynbio.4c00731 Bruckhoff RW Becker O Steinhilber D Suess B ACS synthetic biology Potential and Optimization of Mammalian Splice Riboswitches for the Regulation of Exon Skipping-Dependent Gene Expression and Isoform Switching within the ALOX5 Gene p. 207-232 2019 Xin F et al Elsevier Chapter 9 - Biosynthetic Technology and Bioprocess Engineering, in Current Developments in Biotechnology and Bioengineering, S.P. Singh, et al., Editors p. 339-381 Yeoh JW et al Genetic Circuit Design Principles, in Handbook of Cell Biosensors, G. Thouand, Editor. 2022, Springer International Publishing: Cham. 257 294 2019 Singh S Tiwari BS Elsevier Chapter 11 - Biosynthesis of High-Value Amino Acids by Synthetic Biology, in Current Developments in Biotechnology and Bioengineering, S.P. Singh, et al., Editors 26 1 01 13-26 3 2018 10.1021/acssensors.7b00728 Saltepe B Kehribar ES Su Yirmibeşoğlu SS Şafak Şeker UO ACS sensors Cellular Biosensors with Engineered Genetic Circuits 3 03 1400-1458 8 2008 10.3390/s80314000 Grieshaber D MacKenzie R Vörös J Reimhult E Sensors Electrochemical Biosensors - Sensor Principles and Architectures 25 2 01 64 12 2022 10.3390/bios12020064 Miller CA Ho JML Bennett MR Biosensors Strategies for Improving Small-Molecule Biosensors in Bacteria 12 18-25 54 2018 10.1016/j.copbio.2018.01.011 Lim HG Jang S Jang S Seo SW Jung GY Current Opinion in Biotechnology Design and optimization of genetically encoded biosensors for high-throughput screening of chemicals p. 257-278 Chowdhury A et al Nanotechnology in Diagnostic Imaging, in Nanotechnology Theranostics in Livestock Diseases and Management, M. Prasad, et al., Editors. 2024, Springer Nature Singapore: Singapore 5473244 2022 2022 10.1155/2022/5473244 Du M Wang T Yang Y Zeng F Li Y Chen Z Contrast Media & Molecular Imaging Application of Genetically Encoded Molecular Imaging Probes in Tumor Imaging 30 1 06 1-8 60 2016 10.1042/EBC20150001 Bhalla N Jolly P Formisano N Estrela P Essays in Biochemistry Introduction to biosensors p. 573-628 Kulshreshtha NM Shrivastava D Bisen PS 14 - Contaminant sensors: nanotechnology-based contaminant sensors, in Nanobiosensors, A.M. Grumezescu, Editor. 2017, Academic Press 100075 8 2021 10.1016/j.biosx.2021.100075 Hasan MR Ahommed MS Daizy M Bacchu M Ali M Mamun MR et al Biosensors and Bioelectronics: X Recent development in electrochemical biosensors for cancer biomarkers detection 4 243-247 13 2022 10.4103/japtr.japtr_106_22 Chaudhry G Akim AM Safdar N Yasmin A begum S Sung YY Muhammad TST Journal of Advanced Pharmaceutical Technology & Research Cancer and Disease Diagnosis - Biosensor as Potential Diagnostic Tool for Biomarker Detection 06 07 11 2023 10.3389/fchem.2023.1209744 Xiao Y Zhang Z Yin S Ma X Frontiers in Chemistry Nanoplasmonic biosensors for precision medicine Brazaca, L.C. and J.R. Sempionatto, Chapter 5 - The application of biosensors in precision medicine, in Biosensors in Precision Medicine, L.C. Brazaca and J.R. Sempionatto, Editors. 2024, Elsevier. p. 133-162 30 1 06 59-68 60 2016 10.1042/EBC20150007 Liébana S Drago GA Essays in Biochemistry Bioconjugation and stabilisation of biomolecules in biosensors 01 03 7-28 2 2019 10.1016/j.mne.2018.11.005 Huszka G Gijs MAM Micro and Nano Engineering Super-resolution optical imaging: A comparison 8 01 2511 24 2024 10.3390/s24082511 Jiang W Wang J Yang Y Bu Y Sensors A Review of Microsphere Super-Resolution Imaging Techniques 5 402-420 6 2021 10.1038/s41578-021-00279-y Hofer M Lutolf MP Nature Reviews. Materials Engineering organoids 24 1 05 168 7 2022 10.1038/s41392-022-01024-9 Tang XY Wu S Wang D Chu C Hong Y Tao M Hu H Xu M Guo X Liu Y Signal Transduction and Targeted Therapy Human organoids in basic research and clinical applications 11 1 11 19324 12 2022 10.1038/s41598-022-20998-8 Azizi MMF Romeli S Razali H Ariffin EY Tajol Ariffin MA Heng LY Abu-Bakar N Lau HY Scientific Reports An electrochemical biosensor for the rapid genetic identification of Musang King durian 01 3 05 443-450 9 2016 10.1016/j.arabjc.2014.05.023 Campos-Ferreira DS Souza EVM Nascimento GA Zanforlin DML Arruda MS Beltrão MFS Melo AL Bruneska D Lima-Filho JL Arabian Journal of Chemistry Electrochemical DNA biosensor for the detection of human papillomavirus E6 gene inserted in recombinant plasmid 15 1 01 e0210529 14 2019 10.1371/journal.pone.0210529 Platten JD Cobb JN Zantua RE PLOS ONE Criteria for evaluating molecular markers: Comprehensive quality metrics to improve marker-assisted selection 05 06 176584 972 2024 10.1016/j.ejphar.2024.176584 Laxmi n Golmei P Srivastava S Kumar S European Journal of Pharmacology Single nucleotide polymorphism-based biomarker in primary hypertension 06 2 02 263-277 36 2024 10.1016/j.cmet.2023.11.015 Skinner MK Cell Metabolism Epigenetic biomarkers for disease susceptibility and preventative medicine 2147-2159 21 2023 10.1016/j.csbj.2023.03.032 Chow CN Yang CW Chang WC Computational and Structural Biotechnology Journal Databases and prospects of dynamic gene regulation in eukaryotes: A mini review 05 21 11 8278 21 2020 10.3390/ijms21218278 Pascual-Ahuir A Fita-Torró J Proft M International Journal of Molecular Sciences Capturing and Understanding the Dynamics and Heterogeneity of Gene Expression in the Living Cell 02 16-24 1 2017 10.1016/j.coisb.2016.12.003 Antebi YE Nandagopal N Elowitz MB Current Opinion in Systems Biology An operational view of intercellular signaling pathways 31 1 07 282 8 2023 10.1038/s41392-023-01501-9 Di X Gao X Peng L Ai J Jin X Qi S Li H Wang K Luo D Signal Transduction and Targeted Therapy Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets 1390634 11 2024 10.3389/fmed.2024.1390634 Ghazizadeh E Naseri Z Deigner HP Rahimi H Altintas Z Frontiers in Medicine Approaches of wearable and implantable biosensor towards of developing in precision medicine 5 346-360 1 2023 10.1038/s44222-023-00032-w Wu J Liu H Chen W Ma B Ju H Nature Reviews Bioengineering Device integration of electrochemical biosensors 5 05 497-518 38 2020 10.1016/j.tibtech.2019.12.021 Ho D Quake SR McCabe ERB Chng WJ Chow EK Ding X Gelb BD Ginsburg GS Hassenstab J Ho CM Mobley WC Nolan GP Rosen ST Tan P Yen Y Zarrinpar A Trends in Biotechnology Enabling Technologies for Personalized and Precision Medicine 01 01 100100 2 2021 10.1016/j.sintl.2021.100100 Haleem A Javaid M Singh RP Suman R Rab S Sensors International Biosensors applications in medical field: A brief review 3 03 374-395 41 2023 10.1016/j.tibtech.2022.12.005 Kim ER Joe C Mitchell RJ Gu MB Trends in Biotechnology Biosensors for healthcare: current and future perspectives 29 06 11 2023 10.3389/fbioe.2023.1190211 Zheng Y Liu C Lai NYG Wang Q Xia Q Sun X Zhang S Frontiers in Bioengineering and Biotechnology Current development of biosensing technologies towards diagnosis of mental diseases 04 40 10 14814-14822 294 2019 10.1074/jbc.REV119.006177 Lin W Mehta S Zhang J The Journal of Biological Chemistry Genetically encoded fluorescent biosensors illuminate kinase signaling in cancer 12 7 07 726 13 2023 10.3390/bios13070726 Liu Y Li J Xiao S Liu Y Bai M Gong L Zhao J Chen D Biosensors Revolutionizing Precision Medicine: Exploring Wearable Sensors for Therapeutic Drug Monitoring and Personalized Therapy 5 10 298-313 14 2016 10.1016/j.gpb.2016.03.008 Ahmed S Zhou Z Zhou J Chen SQ Genomics, Proteomics & Bioinformatics Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine 3 e55315 16 10.7759/cureus.55315 Elrobaa IH Khan K Mohamed E Cureus The Role of Point-of-Care Testing to Improve Acute Care and Health Care Services p. 679-705 2022, Springer International Publishing: Cham Karim ME Biosensors: Ethical, Regulatory, and Legal Issues, in Handbook of Cell Biosensors, G. Thouand, Editor 3 09 300-317 4 2024 10.3390/dna4030020 Mondal HS Feng Y Biswas G Hossain MZ DNA Applications and Challenges of DNA-Based Electrochemical Biosensors for Monitoring Health: A Systematic Review 1 07 275-297 53 2024 10.1146/annurev-biophys-030722-021359 Frei MS Mehta S Zhang J Annual Review of Biophysics Next-Generation Genetically Encoded Fluorescent Biosensors Illuminate Cell Signaling and Metabolism 09 1 02 163 7 2024 10.1038/s42003-024-05849-8 Oelsnitz S Stofel SK Love JD Ellington AD Communications Biology Snowprint: a predictive tool for genetic biosensor discovery 15 1 26 11 2017 10.1007/s11705-017-1629-z Wang Q Tang SY Yang S Frontiers of Chemical Science and Engineering Genetic biosensors for small-molecule products: Design and applications in high-throughput screening 01 9 03 2388-2393 113 2016 10.1073/pnas.1600375113 Rogers JK Church GM Proceedings of the National Academy of Sciences of the United States of America Genetically encoded sensors enable real-time observation of metabolite production